Aspirin in secondary prevention of recurrent venous thromboembolism

[1] Vandvik PO(2012)Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 141 e637S-e668S

[2] Lincoff AM(1994)Collaborative overview of randomised trials of antiplatelet therapy–III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients BMJ 308 235-246

[3] Gore JM(2000)Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial Lancet 355 1295-1302

[4] Gutterman DD(2014)Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid J Thrombo Haemost 12 1776-1787

[5] Sonnenberg FA(1980)Trial of dipyridamole-aspirin in recurring venous thrombosis Lancet 2 1328-1329

[6] Alonso-Coello P(2012)Aspirin for preventing the recurrence of venous thromboembolism New Engl J Med 366 1959-1967

[7] Undas A(2012)Low-dose aspirin for preventing recurrent venous thromboembolism New Engl J Med 367 1979-1987

[8] Brummel-Ziedins K(2014)Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration Circulation 130 1062-1071

[9] Mann KG(2012)Aspirin and recurrent venous thromboembolism in patients with symptomatic atherosclerosis: retrospective cohort study J Thrombo Haemost 10 2205-2206

[10] Steele P(1997)The duration of oral anticoagulant therapy after a second episode of venous thromboembolism New Engl J Med 336 393-398

[1] Vandvik PO(2012)Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 141 e637S-e668S

[2] Lincoff AM(1994)Collaborative overview of randomised trials of antiplatelet therapy–III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients BMJ 308 235-246

[3] Gore JM(2000)Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial Lancet 355 1295-1302

[4] Gutterman DD(2014)Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid J Thrombo Haemost 12 1776-1787

[5] Sonnenberg FA(1980)Trial of dipyridamole-aspirin in recurring venous thrombosis Lancet 2 1328-1329

[6] Alonso-Coello P(2012)Aspirin for preventing the recurrence of venous thromboembolism New Engl J Med 366 1959-1967

[7] Undas A(2012)Low-dose aspirin for preventing recurrent venous thromboembolism New Engl J Med 367 1979-1987

[8] Brummel-Ziedins K(2014)Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration Circulation 130 1062-1071

[9] Mann KG(2012)Aspirin and recurrent venous thromboembolism in patients with symptomatic atherosclerosis: retrospective cohort study J Thrombo Haemost 10 2205-2206

[10] Steele P(1997)The duration of oral anticoagulant therapy after a second episode of venous thromboembolism New Engl J Med 336 393-398